Trials / Completed
CompletedNCT02168543
1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers
Clinical Efficacy of Subgingivally Delivered 1% Alendronate in the Treatment of Smokers With Chronic Periodontitis: a Randomized Placebo Controlled Clinical Trial.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Government Dental College and Research Institute, Bangalore · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
* Locally delivered Alendronate (ALN) have potent inhibitory effect on bone and increases new bone formation in chronic periodontitis patients * Till date no study has reported the effect of local delivery of ALN in chronic periodontitis patients among smokers. Hence the aim of this study is to investigate the clinical and radiographic effects of locally delivered ALN as an adjunct to the non surgical treatment in smoker chronic periodontitis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alendronate | |
| DRUG | Placebo |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-01-01
- Completion
- 2011-04-01
- First posted
- 2014-06-20
- Last updated
- 2014-06-20
Source: ClinicalTrials.gov record NCT02168543. Inclusion in this directory is not an endorsement.